UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS SFr in Millions, $ in Millions	6 Months Ended
	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Cash flows from operating activities:
Net income	$ 59.6	$ 135.2
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	79.9	51.0
Stock-based compensation expense	12.2	12.1
Deferred income taxes	(22.3)	9.4
Impairment of minority investments and other long-lived assets	21.6	18.3
Gain on sale of minority investment	0.0	(6.8)
Loss (Gain) on sale of property, plant and equipment	0.8	(9.6)
Other non-cash (income) expenses, net	(7.1)	16.0
Changes in operating assets and liabilities, net of acquisitions and divestitures:
Accounts receivable	29.5	30.5
Inventories	(94.0)	(114.4)
Accounts payable and accrued expenses	5.6	(3.4)
Income taxes payable, net	(22.4)	(17.8)
Deferred revenue and customer advances	2.1	21.1
Other changes in operating assets and liabilities, net	(42.6)	(41.1)
Net cash provided by operating activities	22.9	100.5
Cash flows from investing activities:
Purchases of property, plant and equipment	(46.0)	(48.5)
Proceeds from sale of minority investment	0.0	11.8
Cash paid for minority investments	(10.0)	(9.3)
Cash paid for acquisitions, net of cash acquired	(1,576.5)	(102.7)
Proceeds from sales of property, plant and equipment	0.9	10.7
Net proceeds from cross-currency swap agreements	2.5	3.8
Net cash used in investing activities	(1,629.1)	(134.2)
Cash flows from financing activities:
Repayments of revolving line of credit	(840.1)	0.0
Proceeds from revolving line of credit	1,073.3	0.0
Repayment of other debt, net	(10.5)	(4.5)
Proceeds from 2024 Note Purchase Agreements	472.1	0.0
Proceeds from 2024 Term Loan Agreements	329.5	0.0
Proceeds from long-term debt	4.1	2.8
Repayment of 2012 Note Purchase Agreement	(100.0)	0.0
Repayment of 2019 Term Note Agreement	(7.5)	(7.5)
Payment of deferred financing costs	(5.5)	0.0
Proceeds from Public Offering of common stock, net of issuance costs	402.9	0.0
Proceeds from issuance of common stock, net	5.7	2.8
Payment of contingent consideration	(0.5)	(2.5)
Payment of dividends to common shareholders	(15.0)	(14.7)
Repurchase of common stock	0.0	(22.4)
Proceeds from (payment for) the sale (purchase) of noncontrolling interests	(1.0)	5.0
Net cash provided by (used in) financing activities	1,307.5	(41.0)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(19.7)	4.2
Net change in cash, cash equivalents and restricted cash	(318.4)	(70.5)
Cash, cash equivalents and restricted cash at beginning of period	491.6	648.7
Cash, cash equivalents and restricted cash at end of period	173.2	578.2
Supplemental disclosure of cash flow information:
Restricted cash period beginning balance	3.3	3.2
Restricted cash period ending balance	$ 3.5	$ 3.4